← Back to Clinical Trials
Recruiting NCT05929586

NCT05929586 Digital Data Linkage and Scheduling to Track Pregnancy With or Without Community Data Use to Increase Antenatal Clinic Uptake in Western Kenya.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05929586
Status Recruiting
Phase
Sponsor Liverpool School of Tropical Medicine
Condition Health Systems
Study Type INTERVENTIONAL
Enrollment 1,440 participants
Start Date 2024-11-29
Primary Completion 2026-09-30

Eligibility & Interventions

Sex Female only
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
The combined "C-it DU-it" intervention: community data use for ANC

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,440 participants in total. It began in 2024-11-29 with a primary completion date of 2026-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The investigators propose to increase ANC uptake through a health systems strengthening approach that links digital data platforms and trains community Work Improvement Teams (WITs) to use these data to identify problems and come up with local solutions. Our short name C-it DU-it (pronounced "see-it; do-it") is an acronym intended to convey 'seeing' linked data (C-it) and 'doing' or acting on the data (DU-it). The trial design is a 2-arm, cluster-randomised controlled superiority trial in Homa Bay County to determine the efficacy of 'C-it DU-it' intervention (data use arm) to increase ANC contacts when compared to the 'C-it' enhanced standard of care (control arm).

Eligibility Criteria

Inclusion Criteria: * Pregnant women of all ages willing to participate * Written informed consent * A resident of the study area (catchment area) for the duration of the pregnancy * Delivered and still within the 6-week post-partum period. Exclusion Criteria: * Currently enrolled in another interventional study targeting pregnant women * Outside the 6-week post-partum period.

Contact & Investigator

Central Contact

Hellen C Barsosio, MD

✉ hbarsosio@kemri.go.ke

📞 +254724464507

Principal Investigator

Miriam Taegtmeyer, PhD

PRINCIPAL INVESTIGATOR

Liverpool School of Tropical Medicine

Frequently Asked Questions

Who can join the NCT05929586 clinical trial?

This trial is open to female participants only, studying Health Systems. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05929586 currently recruiting?

Yes, NCT05929586 is actively recruiting participants. Contact the research team at hbarsosio@kemri.go.ke for enrollment information.

Where is the NCT05929586 trial being conducted?

This trial is being conducted at Homa Bay, Kenya.

Who is sponsoring the NCT05929586 clinical trial?

NCT05929586 is sponsored by Liverpool School of Tropical Medicine. The principal investigator is Miriam Taegtmeyer, PhD at Liverpool School of Tropical Medicine. The trial plans to enroll 1,440 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology